Humble Bee Bio Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$1.84M
- Investors
-
17
Humble Bee Bio General Information
Description
Developer of bioplastic products intended to improve global consumer and environmental health with nature-inspired biomaterials. The company uses biomimicry to co-design with nature for manufacturing performance textile finishings, medical devices, and personal care products, enabling clients to create novel biomaterials inspired by nature that improve global environmental health.
Contact Information
Website
www.humblebee.co.nzCorporate Office
- 2/40 Taranaki Street
- Dunedin, 9010
- New Zealand
Corporate Office
- 2/40 Taranaki Street
- Dunedin, 9010
- New Zealand
Humble Bee Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series A) | 20-Jun-2024 | $1.84M | Completed | Generating Revenue | ||
| 3. Later Stage VC (Series A) | 26-May-2022 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jun-2019 | $85.2K | $213K | Completed | Generating Revenue | |
| 1. Later Stage VC | 01-Sep-2018 | $213K | $213K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Humble Bee Bio Patents
Humble Bee Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2025903378-A0 | Bioactive polypeptide | Inactive | 01-Aug-2025 | ||
| WO-2025248490-A1 | Polypeptides from the nesting materials of solitary colletid bees | Pending | 31-May-2024 | ||
| AU-2023403090-A1 | Recombinant polypeptide | Pending | 02-Dec-2022 | ||
| EP-4626911-A1 | Recombinant polypeptide | Pending | 02-Dec-2022 | ||
| US-20260209287-A1 | Recombinant polypeptide | Pending | 02-Dec-2022 | C07K14/43586 |
Humble Bee Bio Signals
Humble Bee Bio Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Radar Ventures (Australia) | Venture Capital | Minority | ||
| Angel HQ | Angel Group | Minority | ||
| Arc Angels | Angel Group | Minority | ||
| Grimley Capital | Venture Capital | Minority | ||
| Icehouse Ventures | Venture Capital | Minority |
Humble Bee Bio FAQs
-
When was Humble Bee Bio founded?
Humble Bee Bio was founded in 2010.
-
Where is Humble Bee Bio headquartered?
Humble Bee Bio is headquartered in Dunedin, New Zealand.
-
What is the size of Humble Bee Bio?
Humble Bee Bio has 8 total employees.
-
What industry is Humble Bee Bio in?
Humble Bee Bio’s primary industry is Biotechnology.
-
Is Humble Bee Bio a private or public company?
Humble Bee Bio is a Private company.
-
What is Humble Bee Bio’s current revenue?
The current revenue for Humble Bee Bio is .
-
How much funding has Humble Bee Bio raised over time?
Humble Bee Bio has raised $5.24M.
-
Who are Humble Bee Bio’s investors?
Radar Ventures (Australia), Angel HQ, Arc Angels, Grimley Capital, and Icehouse Ventures are 5 of 17 investors who have invested in Humble Bee Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process